Projects

Mgr. Andrea Bábelová, PhD.

International

Finished
  • TEmperature-responsive Nanogels for TArgeted delivery of miCroRNAs in wound heaLing and tissue rEgeneration applicationS
    Program: ERANET
    Duration: 1. 2. 2020 – 31. 1. 2024
  • Strategies to strengthen scientific excellence and innovation capacity for early diagnosis of gastrointestinal cancer
    Program: Horizon 2020
    Duration: 1. 10. 2019 – 30. 6. 2023
  • Epigenotoxicity of nanomaterials
    Program: Inter-academic agreement
    Duration: 1. 1. 2020 – 31. 12. 2022
  • In vitro 3-D total cell guidance and fitness
    Program: COST
    Duration: 16. 3. 2017 – 15. 9. 2021

National

Current
  • Effect of Dietary Supplements on Follicular Fluid in Female Infertility: Mitigating Oxidative Stress
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
Finished
  • Novel renal antisense therapy platform for CKD
    Program: SRDA
    Duration: 1. 8. 2021 – 30. 6. 2025
  • Diagnostic of oncological diseases using aptasensors: development and validation
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • Use of microfluidic systems for risk assessment of xenobiotics
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • Preclinical validation of an innovative antisense platform for CML
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Preclinical validation of a SARS-CoV-2-specific RNA inhibitor
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2024
  • Newly syntethized thymol derivatives: relationship between structure and biological activity in colorectal in vitro model.
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • Glycoprofiling of proteins present in serum and exosomes for early prostate cancer diagnostics
    Program: Other projects
    Duration: 1. 12. 2019 – 30. 12. 2022
  • Targeted inhibition of SARS-CoV-2 by a new generation RNA inhibitor
    Program: SRDA
    Duration: 16. 9. 2020 – 31. 12. 2021
  • Gold nanoparticles: impact of physicochemical properties on distribution, accumulation, and biological response in vivo (BIONANOGOLD)
    Program: SRDA
    Duration: 1. 7. 2017 – 30. 6. 2021
  • Induction of apoptosis by betulinic acid coupled to magnetite nanoparticles in human colorectal cell lines
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2020
  • Multivalent morpholino-based antisense system for CML
    Program: SRDA
    Duration: 1. 7. 2016 – 30. 6. 2020
  • Antioxidative, anticarcinogen and photoprotective effects of the essential oil from lavender in vitro.
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2019
  • Mechanisms of gold and magnetic nanoparticle effects on renal cells
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
  • Functional consequences of renal cell activation due to iron oxide and gold nanoparticle uptake
    Program: SASPRO
    Duration: 1. 8. 2015 – 31. 7. 2018
  • Mechanisms of interactions and bystander effect mediated by mesenchymal stromal cells expressing prodrug-converting genes on tumour stem cells
    Program: SRDA
    Duration: 1. 10. 2013 – 30. 9. 2017
  • Mechanism of uptake and trafficking of magnetic iron oxide nanoparticles into human tumor and normal (diploid) cells
    Program: VEGA
    Duration: 1. 1. 2013 – 31. 12. 2016
Employees